Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios Gakis

Showing results (141-150 of 193) with videos related to

Pageof 20
Sort By:
BJU International|January 31, 2013
Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomyTilman Todenhöfer, Jörg Hennenlotter, Philipp Leidenberger, et al.
Journal of Cancer Research and Clinical Oncology|December 4, 2016
Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridizationJohannes Mischinger, Lutz Philipp Guttenberg, Jörg Hennenlotter, et al.
European Urology|December 31, 2013
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelinesJ Alfred Witjes, Eva Compérat, Nigel C Cowan, et al.
Urologie (Heidelberg, Germany)|March 25, 2026
[Perioperative therapy for muscle-invasive bladder cancer-current treatment concepts]Günter Niegisch, Georgios Gakis, Carsten H Ohlmann, et al.
Journal of Endourology|September 13, 2014
Y pouch neobladder-a simplified method of intracorporeal neobladder after robotic cystectomyAllen Sim, Tilman Todenhöfer, Johannes Mischinger, et al.
Disease Markers|January 15, 2015
Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancerTilman Todenhöfer, Jörg Hennenlotter, Michael Esser, et al.
Urologic Oncology|December 17, 2013
Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancerRene Ritter, Jörg Hennenlotter, Ursula Kühs, et al.
European Urology|June 6, 2013
The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literatureGeorgios Gakis, Stephen A Boorjian, Alberto Briganti, et al.
Urologia Internationalis|January 9, 2016
Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder CancerGeorgios Gakis, Michael Rink, Hans-Martin Fritsche, et al.
The Prostate|January 15, 2015
Significance of apoptotic and non-apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancerTilman Todenhöfer, Jörg Hennenlotter, Frank Faber, et al.
Pageof 20

Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
BJU International|January 31, 2013
Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomyTilman Todenhöfer, Jörg Hennenlotter, Philipp Leidenberger, et al.
Journal of Cancer Research and Clinical Oncology|December 4, 2016
Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridizationJohannes Mischinger, Lutz Philipp Guttenberg, Jörg Hennenlotter, et al.
European Urology|December 31, 2013
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelinesJ Alfred Witjes, Eva Compérat, Nigel C Cowan, et al.
Urologie (Heidelberg, Germany)|March 25, 2026
[Perioperative therapy for muscle-invasive bladder cancer-current treatment concepts]Günter Niegisch, Georgios Gakis, Carsten H Ohlmann, et al.
Journal of Endourology|September 13, 2014
Y pouch neobladder-a simplified method of intracorporeal neobladder after robotic cystectomyAllen Sim, Tilman Todenhöfer, Johannes Mischinger, et al.
Disease Markers|January 15, 2015
Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancerTilman Todenhöfer, Jörg Hennenlotter, Michael Esser, et al.
Urologic Oncology|December 17, 2013
Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancerRene Ritter, Jörg Hennenlotter, Ursula Kühs, et al.
European Urology|June 6, 2013
The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literatureGeorgios Gakis, Stephen A Boorjian, Alberto Briganti, et al.
Urologia Internationalis|January 9, 2016
Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder CancerGeorgios Gakis, Michael Rink, Hans-Martin Fritsche, et al.
The Prostate|January 15, 2015
Significance of apoptotic and non-apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancerTilman Todenhöfer, Jörg Hennenlotter, Frank Faber, et al.
Pageof 20